These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 26394281

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Biochanin A Protects Against Lipopolysaccharide-Induced Damage of Dopaminergic Neurons Both In Vivo and In Vitro via Inhibition of Microglial Activation.
    Wang J, Wu WY, Huang H, Li WZ, Chen HQ, Yin YY.
    Neurotox Res; 2016 Oct; 30(3):486-98. PubMed ID: 27417698
    [Abstract] [Full Text] [Related]

  • 3. Biochanin A protects dopaminergic neurons against lipopolysaccharide-induced damage through inhibition of microglia activation and proinflammatory factors generation.
    Chen HQ, Jin ZY, Li GH.
    Neurosci Lett; 2007 May 01; 417(2):112-7. PubMed ID: 17399896
    [Abstract] [Full Text] [Related]

  • 4. [Protective effect of alkaloids from Piper longum in rat dopaminergic neuron injury of 6-OHDA-induced Parkinson's disease].
    Zheng L, Wang H, Ba YY, Liu HL, Wang M, Guo WW, Wu X, Yang H.
    Zhongguo Zhong Yao Za Zhi; 2014 May 01; 39(9):1660-5. PubMed ID: 25095380
    [Abstract] [Full Text] [Related]

  • 5. Somatostatin prevents lipopolysaccharide-induced neurodegeneration in the rat substantia nigra by inhibiting the activation of microglia.
    Bai L, Zhang X, Li X, Liu N, Lou F, Ma H, Luo X, Ren Y.
    Mol Med Rep; 2015 Jul 01; 12(1):1002-8. PubMed ID: 25777539
    [Abstract] [Full Text] [Related]

  • 6. Apocyanin, a Microglial NADPH Oxidase Inhibitor Prevents Dopaminergic Neuronal Degeneration in Lipopolysaccharide-Induced Parkinson's Disease Model.
    Sharma N, Nehru B.
    Mol Neurobiol; 2016 Jul 01; 53(5):3326-3337. PubMed ID: 26081143
    [Abstract] [Full Text] [Related]

  • 7. Post-treatment with an ultra-low dose of NADPH oxidase inhibitor diphenyleneiodonium attenuates disease progression in multiple Parkinson's disease models.
    Wang Q, Qian L, Chen SH, Chu CH, Wilson B, Oyarzabal E, Ali S, Robinson B, Rao D, Hong JS.
    Brain; 2015 May 01; 138(Pt 5):1247-62. PubMed ID: 25716193
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. β-Caryophyllene, a phytocannabinoid attenuates oxidative stress, neuroinflammation, glial activation, and salvages dopaminergic neurons in a rat model of Parkinson disease.
    Ojha S, Javed H, Azimullah S, Haque ME.
    Mol Cell Biochem; 2016 Jul 01; 418(1-2):59-70. PubMed ID: 27316720
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characterization of the lipopolysaccharide induced model of Parkinson's disease: Role of oxidative stress and neuroinflammation.
    Sharma N, Nehru B.
    Neurochem Int; 2015 Aug 01; 87():92-105. PubMed ID: 26055970
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Melatonin protects against behavioral deficits, dopamine loss and oxidative stress in homocysteine model of Parkinson's disease.
    Paul R, Phukan BC, Justin Thenmozhi A, Manivasagam T, Bhattacharya P, Borah A.
    Life Sci; 2018 Jan 01; 192():238-245. PubMed ID: 29138117
    [Abstract] [Full Text] [Related]

  • 14. Edaravone protects neurons in the rat substantia nigra against 6-hydroxydopamine-induced oxidative stress damage.
    Liu X, Shao R, Li M, Yang G.
    Cell Biochem Biophys; 2014 Nov 01; 70(2):1247-54. PubMed ID: 24948472
    [Abstract] [Full Text] [Related]

  • 15. Lycopodium Attenuates Loss of Dopaminergic Neurons by Suppressing Oxidative Stress and Neuroinflammation in a Rat Model of Parkinson's Disease.
    Jayaraj RL, Beiram R, Azimullah S, Meeran MFN, Ojha SK, Adem A, Jalal FY.
    Molecules; 2019 Jun 10; 24(11):. PubMed ID: 31185705
    [Abstract] [Full Text] [Related]

  • 16. The neuroprotective effects of hydro-alcoholic extract of olive (Olea europaea L.) leaf on rotenone-induced Parkinson's disease in rat.
    Sarbishegi M, Charkhat Gorgich EA, Khajavi O, Komeili G, Salimi S.
    Metab Brain Dis; 2018 Feb 10; 33(1):79-88. PubMed ID: 29039078
    [Abstract] [Full Text] [Related]

  • 17. Clozapine metabolites protect dopaminergic neurons through inhibition of microglial NADPH oxidase.
    Jiang L, Wu X, Wang S, Chen SH, Zhou H, Wilson B, Jin CY, Lu RB, Xie K, Wang Q, Hong JS.
    J Neuroinflammation; 2016 May 16; 13(1):110. PubMed ID: 27184631
    [Abstract] [Full Text] [Related]

  • 18. Anti-oxidant polydatin (piceid) protects against substantia nigral motor degeneration in multiple rodent models of Parkinson's disease.
    Chen Y, Zhang DQ, Liao Z, Wang B, Gong S, Wang C, Zhang MZ, Wang GH, Cai H, Liao FF, Xu JP.
    Mol Neurodegener; 2015 Mar 02; 10():4. PubMed ID: 26013581
    [Abstract] [Full Text] [Related]

  • 19. Involvement of NADPH oxidase and glutathione in zinc-induced dopaminergic neurodegeneration in rats: similarity with paraquat neurotoxicity.
    Kumar A, Singh BK, Ahmad I, Shukla S, Patel DK, Srivastava G, Kumar V, Pandey HP, Singh C.
    Brain Res; 2012 Feb 15; 1438():48-64. PubMed ID: 22244881
    [Abstract] [Full Text] [Related]

  • 20. Apocyanin, NADPH oxidase inhibitor prevents lipopolysaccharide induced α-synuclein aggregation and ameliorates motor function deficits in rats: Possible role of biochemical and inflammatory alterations.
    Sharma N, Kapoor M, Nehru B.
    Behav Brain Res; 2016 Jan 01; 296():177-190. PubMed ID: 26367469
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.